Implementation of rapid and frequent SARS-CoV2 antigen testing and response in congregate homeless shelters.
PLoS One
; 17(3): e0264929, 2022.
Article
in English
| MEDLINE | ID: covidwho-1938420
ABSTRACT
BACKGROUND:
People experiencing homelessness who live in congregate shelters are at high risk of SARS-CoV2 transmission and severe COVID-19. Current screening and response protocols using rRT-PCR in homeless shelters are expensive, require specialized staff and have delays in returning results and implementing responses.METHODS:
We piloted a program to offer frequent, rapid antigen-based tests (BinaxNOW) to residents and staff of congregate-living shelters in San Francisco, California, from January 15th to February 19th, 2021. We used the Reach-Effectiveness-Adoption-Implementation-Maintenance (RE-AIM) framework to evaluate the implementation.RESULTS:
Reach We offered testing at ten of twelve eligible shelters. Shelter residents and staff had variable participation across shelters; approximately half of eligible individuals tested at least once; few tested consistently during the study. Effectiveness 2.2% of participants tested positive. We identified three outbreaks, but none exceeded 5 cases. All BinaxNOW-positive participants were isolated or left the shelters. Adoption We offered testing to all eligible participants within weeks of the project's initiation. Implementation Adaptations made to increase reach and improve consistency were promptly implemented. Maintenance San Francisco Department of Public Health expanded and maintained testing with minimal support after the end of the pilot.CONCLUSION:
Rapid and frequent antigen testing for SARS-CoV2 in homeless shelters is a viable alternative to rRT-PCR testing that can lead to immediate isolation of infectious individuals. Using the RE-AIM framework, we evaluated and adapted interventions to enable the expansion and maintenance of protocols.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Ill-Housed Persons
/
COVID-19 Serological Testing
/
COVID-19
Type of study:
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
PLoS One
Journal subject:
Science
/
Medicine
Year:
2022
Document Type:
Article
Affiliation country:
Journal.pone.0264929
Similar
MEDLINE
...
LILACS
LIS